Macrogenics (MGNX) Non-Current Deffered Revenue (2012 - 2025)

Macrogenics (MGNX) has 14 years of Non-Current Deffered Revenue data on file, last reported at $55.5 million in Q4 2025.

• On a quarterly basis, Non-Current Deffered Revenue changed 0.0% year-over-year to $55.5 million in Q4 2025; TTM through Dec 2025 was $55.5 million, a 0.0% change from a year earlier, with the FY2025 full-year figure at $55.5 million, changed 0.0% from the prior year.
• Non-Current Deffered Revenue for Q4 2025 stood at $55.5 million, down from $55.8 million in the prior quarter.
• Over the last five years, Non-Current Deffered Revenue for MGNX reached as high as $64.3 million in Q3 2023 and fell as low as $7.3 million in Q1 2021.
• Historically, Non-Current Deffered Revenue has averaged $49.8 million across 5 years, with a median of $55.9 million in 2025.
• Across the five-year window, Non-Current Deffered Revenue soared 690.63% in 2022 and slipped 13.63% in 2024, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $9.6 million in 2021, then soared by 521.2% to $59.5 million in 2022, then fell by 0.4% to $59.2 million in 2023, then slipped by 6.31% to $55.5 million in 2024, then changed by 0.0% to $55.5 million in 2025.
• Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $55.5 million in Q4 2025, $55.8 million in Q3 2025, and $55.7 million in Q2 2025.